- Use for an adult with undifferentiated chest pain in the emergency department after an initial history, 12-lead EKG, and a cardiac troponin have been obtained.
- Score each of the five components (History, EKG, Age, Risk factors, Troponin) 0, 1, or 2 using the definitions below.
- The total HEART Score is 0–10. The risk band and recommended disposition update automatically.
- Low (0–3) → consider discharge with outpatient follow-up; moderate (4–6) → admit for observation with serial troponins; high (7–10) → early invasive strategy.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Use the HEART Score in adult emergency-department patients presenting with chest pain in whom acute coronary syndrome (ACS) is a diagnostic consideration. The score is designed to be applied after the first round of workup (history, 12-lead EKG, and a baseline cardiac troponin) to stratify 6-week MACE (major adverse cardiac events: all-cause mortality, acute myocardial infarction, or coronary revascularization) and support disposition decisions in the emergency department.
Appropriate population
Adults ≥ 21 years old with chest pain of suspected cardiac origin, in whom the clinician is considering discharge versus admission. Validated in multicenter European and North American emergency-department cohorts; the HEART Pathway trial added a serial 0/3-hour troponin to safely discharge low-risk patients.
When NOT to rely on it
Do not apply to patients with new ST-elevation myocardial infarction (STEMI), hemodynamic instability, ongoing unstable angina, or an alternative diagnosis already established (aortic dissection, pulmonary embolism). The score does not replace clinical gestalt in high-pretest-probability patients — a HEART Score of 3 in a 70-year-old with crescendo angina and dynamic EKG changes is not a "low-risk" patient. The score has been validated with conventional (not high-sensitivity) troponin; interpretation with high-sensitivity assays should pair with the HEART Pathway or an institutional protocol.
Pearls & Pitfalls
History is a clinician judgment
The History item rewards typical features (substernal pressure, exertional, radiation to arm or jaw, diaphoresis, nausea) and penalizes atypical features (sharp, pleuritic, positional, reproducible on palpation). Mixed presentations score 1. Be honest: a borderline history should not be downscored to pull a patient into the low-risk band.
Risk factors are counted, not weighted
Count hypertension, hypercholesterolemia, diabetes mellitus, obesity (body mass index > 30), current smoking (or cessation within 90 days), family history of premature coronary artery disease, and a personal history of atherosclerotic disease. Any history of atherosclerotic disease (prior myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft, stroke, transient ischemic attack, or peripheral arterial disease) automatically scores 2 regardless of the count.
Pitfalls
(1) The score has been validated for 6-week MACE — it does not predict in-hospital mortality, 30-day events, or 1-year outcomes directly. (2) A single baseline troponin can miss an evolving infarct; the HEART Pathway adds a 3-hour troponin for serial sampling and safe discharge. (3) A "normal" EKG in this scoring scheme means no ST deviation and no bundle-branch block or pre-excitation; left bundle branch block, left ventricular hypertrophy strain, or digitalis effect all count as 1, not 0. (4) Obesity requires body mass index > 30 — do not score it on appearance alone.
Why Use It
Chest pain is one of the most common reasons for emergency-department presentation and one of the costliest to work up. Most patients do not have acute coronary syndrome, but missing the ones who do is dangerous. The HEART Score, derived by Six, Backus, and colleagues and prospectively validated in multiple cohorts, gives a defensible, structured answer to the question "Can this patient safely go home?" It rests on five readily available data points (no advanced imaging, no exercise testing) and has been shown to identify a substantial low-risk group (score 0–3) in whom 6-week MACE is approximately 1–2% — a rate low enough that the HEART Pathway randomized trial confirmed safe early discharge without reducing clinically significant events. Compared with the older TIMI and GRACE scores, the HEART Score was derived specifically for undifferentiated emergency-department chest pain rather than confirmed acute coronary syndrome, which is why it is now the first-line tool in most emergency-department chest-pain pathways.
HEART Score for Chest Pain
Pick a value for each of the five items. The total HEART Score, risk band, 6-week MACE probability, and recommended disposition update automatically.
⚕ Six AJ, Backus BE, Kelder JC. Neth Heart J. 2008;16(6):191–196. Backus BE et al. Int J Cardiol. 2013;168(3):2153–2158. Mahler SA et al. Circ Cardiovasc Qual Outcomes. 2015;8(2):195–203. The HEART Score is validated for 6-week MACE in undifferentiated emergency-department chest pain; it does not replace clinical judgment or exclude non-cardiac life-threats. For licensed clinicians; not a substitute for individualized assessment.
Next Steps
Use the HEART Score band to direct disposition, then pair with a serial troponin strategy and shared decision-making.
- Score 0–3 (low risk, approximately 1.7% MACE): consider early discharge from the emergency department with outpatient follow-up. Patients enrolled in the HEART Pathway add a 3-hour troponin before discharge, which has been shown in a randomized trial to safely cut hospital length of stay and admission without increasing missed events.
- Score 4–6 (moderate risk, approximately 16.6% MACE): admit for observation with serial troponins and further non-invasive risk assessment (stress testing or coronary CT angiography depending on local resources).
- Score 7–10 (high risk, approximately 50.1% MACE): early invasive strategy — admit, cardiology consult, and consider early coronary angiography; manage acute coronary syndrome by current guidelines.
- Pair this with the TIMI risk score for unstable angina/NSTEMI once the diagnosis is confirmed, and use the GRACE ACS risk for in-hospital and 6-month mortality in admitted ACS.
Evidence & References
Scoring Components
| Component | 0 points | 1 point | 2 points |
|---|---|---|---|
| H — History | Slightly suspicious | Moderately suspicious | Highly suspicious |
| E — EKG | Normal | Non-specific repolarization | Significant ST deviation |
| A — Age (yrs) | < 45 | 45 – 64 | ≥ 65 |
| R — Risk factors | None | 1 – 2 | ≥ 3 or known atherosclerotic disease |
| T — Troponin | ≤ normal limit | 1 – 3 × normal limit | > 3 × normal limit |
Risk Bands and 6-week MACE (Backus 2013, n = 2440)
| Score | 6-week MACE | Disposition |
|---|---|---|
| 0 – 3 (low) | 1.7% | Discharge with outpatient follow-up (or HEART Pathway with 0/3-h troponin) |
| 4 – 6 (moderate) | 16.6% | Admit for observation, serial troponins, non-invasive risk assessment |
| 7 – 10 (high) | 50.1% | Early invasive strategy |
MACE is defined as the composite of all-cause mortality, acute myocardial infarction, or coronary revascularization at 6 weeks after presentation. Numbers are from the Backus 2013 prospective multicenter validation.
References
- Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008;16(6):191–196. doi:10.1007/BF03086144.
- Backus BE, Six AJ, Kelder JC, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013;168(3):2153–2158. doi:10.1016/j.ijcard.2013.01.255.
- Mahler SA, Riley RF, Hiestand BC, et al. The HEART Pathway randomized controlled trial. Circ Cardiovasc Qual Outcomes. 2015;8(2):195–203. doi:10.1161/CIRCOUTCOMES.114.001384.
